Davis Polk advised the joint book-running managers on a Rule 144A / Regulation S offering by Wyndham Hotels & Resorts, Inc. of $500 million aggregate principal amount of 5.375%…
Davis Polk advised the representatives of the several initial purchasers in connection with a Rule 144A/Regulation S offering by Coty Inc. of $550 million aggregate principal amount of…
Davis Polk advised Charles River Laboratories International, Inc. in connection with its Rule 144A/Regulation S offering of $500 million aggregate principal amount of 5.500% senior notes…
Davis Polk advised Valeant Pharmaceuticals International, Inc. (“Valeant”) in connection with a refinancing transaction pursuant to which its indirect wholly owned subsidiary, Valeant…
Davis Polk advised the underwriters in connection with a Regulation S offering by CNAC (HK) Finbridge Company Limited, an indirectly wholly owned subsidiary of China National Chemical…
Davis Polk advised Equinix, Inc. on its SEC-registered offering of €750 million aggregate principal amount of 2.875% senior notes due 2024.Equinix, Inc. connects more than 9,800 companies…
Davis Polk advised the joint book-running managers and the initial purchasers in a Rule 144A/Regulation S offering of $325 million principal amount of senior notes due 2026 of WMG…
Davis Polk advised the initial purchasers in connection with a $250 million Regulation S only offering by Logan Property Holdings Company Limited of its 6.375% senior notes due 2021…
Davis Polk advised the representative of the initial purchasers in connection with a $500 million notes offering by Pilgrim’s Pride Corporation, including $250 million of 5.750% senior…
Davis Polk advised the initial purchasers in connection with the $300 million Regulation S offering by Central China Real Estate Limited of its 6.50% senior notes due 2021.
CCRE…